Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia.
about
Clinical review: Evidence-based perioperative medicine?Combined use of ultra-short acting beta-blocker esmolol and intravenous phosphodiesterase 3 inhibitor enoximoneMeta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery.Peri-operative beta-blockade and haemodynamic optimisation in patients with coronary artery disease and decreasing exercise capacity presenting for major noncardiac surgery.Effect of chronic beta-blockade on peri-operative outcome in patients undergoing non-cardiac surgery: an analysis of observational and case control studies.How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials.Reducing risk of cardiovascular events in noncardiac surgery.The pharmacoeconomics of peri-operative beta-blocker therapy.Acute peri-operative beta blockade in intermediate-risk patients.Clinical Review: Is the perioperative use of beta-blockers still recommended? A critical review of recent controversies.Beta-blockers and risk of all-cause mortality in non-cardiac surgery.Risk of adverse events after coronary artery bypass graft and subsequent noncardiac surgery.Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension.Clinical pharmacokinetics and therapeutic efficacy of esmolol.Influence of esmolol on requirement of inhalational agent using entropy and assessment of its effect on immediate postoperative pain score.The one year incidence of postoperative myocardial infarction in an orthopedic population.Improving Quality and Decreasing Cost by Reducing Re-admissions in Patients Undergoing Total Joint Arthroplasty.Neuropathic symptoms following continuous popliteal block after foot and ankle surgery.The management of patients with ischaemic heart disease undergoing non-cardiac elective surgery: a survey of Australian and New Zealand clinical practice.Bolus application of landiolol and esmolol: comparison of the pharmacokinetic and pharmacodynamic profiles in a healthy Caucasian group.Gaining control: can we reduce perioperative cardiovascular complications?
P2860
Q24801983-57F5D917-9C3C-4BA8-AE12-3F2D074CC708Q28241758-E8C42092-AC18-4D48-98C9-DC8A4C31A4AEQ34361033-93E07570-BE58-4A60-918E-EB5BA50261ABQ35612101-82D608F6-89D7-4328-8664-12C16AC38FF4Q35773536-68097A85-F81E-42D3-B46B-6B1CAF262E14Q36183773-28E712BB-087A-4F75-AF2C-C1CF109AEDE8Q36221974-A713BDD3-0F52-4CEE-AB8D-3CFB8D02AC45Q36366987-0C176F1F-8920-486F-96AE-EBA374ADBC9DQ36595236-CE6AAAFD-9C6E-4F84-B0A9-99F414EB2B71Q37592881-6EB71E46-F131-4537-BD29-122DD2FF243BQ37702033-00F3AFF9-1CBE-4407-8A23-F8720D6ED211Q37822725-07325712-7BE9-4B79-8B3F-2F0AB4F14648Q37970761-5F463457-3307-4309-A9E4-6EA9E9474A61Q38003695-E4175FBA-B89A-4412-B3DB-5D528F2F4C60Q39234324-744C9D20-50E0-4BE1-AADB-14F7CA9F303DQ39858686-92C4C13C-5B62-48FA-BA15-39792330170FQ41566788-EECD83F2-8655-404E-8DD8-810F11FFA8B7Q48151909-BAF131E7-ECF7-4286-9D0F-77B23DCE2D85Q48893297-97CB5FDD-D96D-46E5-9848-BB0752EC7BD5Q53533737-DE2779E5-21DD-4E4A-B7BA-490A184DAD12Q54131740-285E1EF6-29F6-49CF-A3F3-0015AD14A724
P2860
Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Postoperative prophylactic adm ...... risk for myocardial ischemia.
@en
Postoperative prophylactic adm ...... risk for myocardial ischemia.
@nl
type
label
Postoperative prophylactic adm ...... risk for myocardial ischemia.
@en
Postoperative prophylactic adm ...... risk for myocardial ischemia.
@nl
prefLabel
Postoperative prophylactic adm ...... risk for myocardial ischemia.
@en
Postoperative prophylactic adm ...... risk for myocardial ischemia.
@nl
P2093
P1476
Postoperative prophylactic adm ...... risk for myocardial ischemia.
@en
P2093
B L Urquhart
M A Gordon
P Kligfield
S M Markowitz
P304
P356
10.1097/00000539-200006000-00001
P407
P577
2000-06-01T00:00:00Z